Geron (GERN) Interest Coverage Ratio (2010 - 2026)

Geron's (GERN) quarterly Interest Coverage Ratio came in at 0.02 in Q1 2026, up 101.09% year-on-year from 0.01 in Q1 2025, and up 100.63% quarter-over-quarter from 3.5 in Q4 2025.

Geron (GERN) Interest Coverage Ratio (2010 - 2026) Analysis & Trends

Geron has disclosed Interest Coverage Ratio across 17 years of filings, most recently posting 0.02 for Q1 2026.

  • Interest Coverage Ratio for Q1 2026 came in at 0.02, up 101.09% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.64 (up 71.64% YoY), and the FY2025 annual result was 2.1, up 77.63% from the prior year.
  • Interest Coverage Ratio came in at 0.02 for Q1 2026 at Geron, up from 3.5 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 0.02 in Q1 2026 to a low of 25.94 in Q2 2023.
  • The 5-year median for Interest Coverage Ratio is 17.7 (2022), against an average of 13.57.
  • Across the five-year window, Interest Coverage Ratio sank 51.98% in 2025 and jumped 101.09% in 2026, its largest moves.
  • Geron's Interest Coverage Ratio stood at 20.92 in 2022, then fell by 11.79% to 23.39 in 2023, then jumped by 90.15% to 2.3 in 2024, then slumped by 51.98% to 3.5 in 2025, then jumped by 100.63% to 0.02 in 2026.
  • The last three Interest Coverage Ratio figures came in at 0.02 (Q1 2026), 3.5 (Q4 2025), and 1.61 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 3.58
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -258.33
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 11.50
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 547.67
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - 11.79
10 Geron 729,618.77 729,618.77 - 0.02

Historic Data

Download Data
DateValue
Mar 31, 2026 0.02
Dec 31, 2025 -3.50
Sep 30, 2025 -1.61
Jun 30, 2025 -1.46
Mar 31, 2025 -2.04
Dec 31, 2024 -2.30
Sep 30, 2024 -9.26
Jun 30, 2024 -20.89
Mar 31, 2024 -16.35
Dec 31, 2023 -23.39
Sep 30, 2023 -23.05
Jun 30, 2023 -25.94
Mar 31, 2023 -20.86
Dec 31, 2022 -20.92
Sep 30, 2022 -21.99
Jun 30, 2022 -17.70
Mar 31, 2022 -19.39
Dec 31, 2021 -27.30
Sep 30, 2021 -24.27
Jun 30, 2021 -35.93